Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01975584 · ClinicalTrials.gov registry record · NA

Neuroendocrine and Immune Response to Stress in Schizophrenia

A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT01975584 is a NA study of Schizophrenia and Schizoaffective Disorder that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 21 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01975584, a NA study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study. We are testing the physiologic, immune and chemical responses to stress. We believe the results of all measures to stress will be blunted in schizophrenia compared to healthy controls. We will test sex, early life stress and other factors on the relationship to a stress response.

Interventions

  • BEHAVIORAL Trier Social Stress Test

Study Locations (1)

Maryland

  • Maryland Psychiatric Research Center - Catonsville

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2013-09
Est. Completion 2018-06
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT01975584

The ClinicalTrials.gov registry entry for NCT01975584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (90% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Trier Social Stress Test is the first listed.

NCT01975584 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01975584 about?

NCT01975584 is a clinical study titled "Neuroendocrine and Immune Response to Stress in Schizophrenia". This is a pilot study. We are testing the physiologic, immune and chemical responses to stress. We believe the results of all measures to stress will be blunted in schizophrenia compared to healthy controls. We will test sex, early life stress and other factors on the relationship to a stress respon...

What is the current status of trial NCT01975584?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2013-09. Estimated completion is 2018-06.

What conditions does trial NCT01975584 study?

This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.

What interventions are being tested in trial NCT01975584?

The interventions under investigation include: Trier Social Stress Test (BEHAVIORAL).

Who is sponsoring clinical trial NCT01975584?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01975584 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.